| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1793 |
| Trial ID | NCT03299738 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | C-CAR011 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL |
| Year | 2017 |
| Country | China |
| Company sponsor | Cellular Biomedicine Group Ltd. |
| Other ID(s) | CBMG-C2017006 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||